Understanding Suicidal Ideation: What It Is, What to Do, and How Treatment Helps

Not all suicidal thoughts are the same, and the difference between passive and active ideation is clinically significant. Understanding this distinction helps both individuals and their loved ones communicate more accurately about what is happening — and helps clinicians assess and respond appropriately.

Passive suicidal ideation involves thoughts about death or dying without a specific intent or plan. This might look like “I wish I could go to sleep and not wake up,” “I wouldn't care if I got in a car accident,” or “Everyone would be better off without me.” These thoughts are extremely common — research suggests that up to 1 in 6 Americans experiences passive suicidal ideation at some point in their lives.

Active suicidal ideation involves a specific wish to die, often accompanied by thinking about when, where, or how. Active ideation — especially with a plan and access to means — represents a clinical emergency requiring immediate intervention. If you are experiencing active suicidal ideation right now, please call or text 988.

Both passive and active suicidal ideation are symptoms that deserve clinical attention. The presence of passive ideation does not mean someone is fine — it means they are suffering in a way that needs professional support.

Suicidal ideation is far more prevalent than most public discourse suggests. According to the Substance Abuse and Mental Health Services Administration (SAMHSA):

• Approximately 12.3 million American adults seriously thought about suicide in 2021
• 3.5 million adults made a suicide plan
• 1.7 million adults made a suicide attempt
• Suicidal ideation is highest among adults aged 18–25, followed by adolescents aged 12–17

These numbers are not meant to minimize the severity of suicidal thinking — they are meant to reduce the isolation and shame that so often accompany it. If you have had suicidal thoughts, you are not uniquely broken or dangerous. You are experiencing a symptom of psychiatric suffering that millions of people share — and that responds to treatment.

Most people experiencing suicidal ideation do not walk up to someone and say “I want to die.” Shame, fear of hospitalization, fear of burdening others, and the belief that no one can help all contribute to silence. Instead, warning signs are often indirect. Family members, friends, and clinicians who know what to listen for are better positioned to open a conversation before a crisis escalates.

Verbal warning signs

• “I'm so tired of everything.”
• “I don't see the point anymore.”
• “Everyone would be better off without me.”
• “I just want it to stop.”
• “I won't be a problem much longer.”

Behavioral warning signs

• Withdrawal from friends, family, and activities
• Giving away prized possessions or making arrangements (as if preparing to leave)
• Sudden calmness after a period of severe depression
• Increased risk-taking behavior or recklessness with personal safety
• Changes in sleep — either severe insomnia or sleeping excessively
• Researching or acquiring means

If you notice these signs in someone you care about, ask directly: “I've noticed you seem like you're in a lot of pain. Are you having thoughts of ending your life?” Asking does not plant the idea. It opens the door.

Suicidal ideation is not simply a logical response to difficult circumstances — it has a measurable neurobiological substrate. Understanding the biology does not remove personal agency or meaning from suicidal experience, but it does help explain why suicidal crises can feel sudden, overwhelming, and outside of rational control.

Serotonin system dysregulation

Post-mortem brain studies of individuals who died by suicide consistently show reduced serotonin activity in the prefrontal cortex — the brain region responsible for impulse control, planning, and decision-making. Low serotonin activity in this area is associated with impulsivity, poor emotion regulation, and reduced ability to inhibit suicidal impulses.

HPA Axis dysregulation

The hypothalamic-pituitary-adrenal (HPA) axis governs the body's stress response. Dysregulation of the HPA axis — elevated baseline cortisol, blunted cortisol response — is seen in both suicidal ideation and suicide attempts. Chronic stress and early adversity produce lasting changes to the HPA axis that increase vulnerability to suicidal crises in adulthood.

The pain and perturbation model

Psychologist Edwin Shneidman described suicidal crises as emerging from psychache — intense, unbearable psychological pain — combined with perturbation(extreme agitation or urgency). This model helps explain why suicidal crises often involve a narrowing of cognitive flexibility — the mind becomes convinced that death is the only way to end the pain, while being temporarily unable to access other perspectives.

Suicidal ideation responds to treatment. The goal is not just safety in the immediate crisis — it is building the skills, support systems, and neurobiological stability that reduce the likelihood of suicidal crises occurring. Evidence-based approaches include:

Safety Planning

Safety planning — developed by Barbara Stanley and Gregory Brown — is the most widely validated intervention for reducing suicidal behavior. A safety plan is a personalized, prioritized set of steps that an individual follows when suicidal ideation escalates. It includes warning sign recognition, internal coping strategies, social distraction options, people to contact for support, and crisis line numbers. The Stanley-Brown Safety Planning Intervention (SPI) reduces suicide attempts by approximately 45% compared to no intervention in emergency department settings.

Cognitive Behavioral Therapy (CBT) for Suicide

CBT-based suicide prevention — including Cognitive Therapy for Suicide Prevention (CT-SP) — targets the hopelessness, cognitive rigidity, and problem-solving deficits that elevate suicide risk. It helps patients identify the thought patterns that generate suicidal cognitions (“I am a burden,” “there is no way out”) and build flexibility and alternative perspectives.

Dialectical Behavior Therapy (DBT)

DBT was originally developed specifically to treat chronically suicidal patients with borderline personality disorder, and it remains one of the most evidence-based treatments for suicidal ideation and behavior across diagnostic groups. DBT's distress tolerance skills are particularly important for suicidal crises — they provide concrete, practiced strategies for surviving overwhelming emotional pain without acting on it.

Medication does not eliminate suicidal ideation on its own, but it plays a significant evidence-based role in reducing the neurobiological vulnerability that drives it.

Antidepressants

SSRIs and SNRIs are first-line for major depressive disorder and anxiety disorders — the conditions most commonly associated with suicidal ideation. It is important to know that antidepressants carry an FDA black box warning for increased suicidal ideation in children, adolescents, and young adults under 25 in the early weeks of treatment. This does not mean antidepressants should be avoided — but it does mean careful monitoring in the first 4 weeks, especially in younger patients. Discuss this explicitly with your prescriber.

Lithium

Lithium has the strongest evidence of any medication for long-term reduction in suicide risk. Meta-analyses show that lithium reduces the risk of completed suicide and suicide attempts by approximately 60–80% in patients with bipolar disorder — and the evidence extends to unipolar depression as well. The mechanism is not fully understood but may involve serotonin enhancement, neuroprotection, and reduction of impulsivity. If you have recurrent suicidal ideation and are not currently on lithium, this is worth asking your prescriber about.

Clozapine

Clozapine is the only medication with an FDA indication specifically for reducing suicidal behavior — in patients with schizophrenia and schizoaffective disorder. It requires careful monitoring but is a meaningful option for patients with psychosis-related suicidal ideation.

Ketamine and esketamine (Spravato)

Ketamine-based treatments have shown rapid reduction of suicidal ideation — sometimes within hours — in research settings and are increasingly used in treatment-resistant contexts. Esketamine (Spravato) is FDA-approved for treatment-resistant depression and can be considered when other options have failed.

If you are worried about someone, here is what the evidence says helps — and what doesn't.

What helps: Asking directly about suicidal thoughts. Listening without judgment. Helping them connect with professional support. Reducing access to means where possible. Staying present — the most powerful thing you can offer is not fixing the problem but being willing to sit with the person in their pain.

What doesn't help: Minimizing (“you have so much to live for”), problem-solving before listening (“have you tried exercise?”), or expressing shock or judgment about the thoughts themselves. If someone has trusted you enough to disclose suicidal ideation, receiving that disclosure with anything other than calm, caring attention closes the door.

If you are supporting someone in active crisis, stay with them and call or text 988 together. If there is immediate danger, call 911.